Viemed Healthcare Inc
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive … Read more
Viemed Healthcare Inc (VMD) - Net Assets
Latest net assets as of September 2025: $135.50 Million USD
Based on the latest financial reports, Viemed Healthcare Inc (VMD) has net assets worth $135.50 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($202.36 Million) and total liabilities ($66.86 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $135.50 Million |
| % of Total Assets | 66.96% |
| Annual Growth Rate | 31.79% |
| 5-Year Change | 63.17% |
| 10-Year Change | 1044.02% |
| Growth Volatility | 28.39 |
Viemed Healthcare Inc - Net Assets Trend (2014–2024)
This chart illustrates how Viemed Healthcare Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Viemed Healthcare Inc (2014–2024)
The table below shows the annual net assets of Viemed Healthcare Inc from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $133.30 Million | +17.04% |
| 2023-12-31 | $113.89 Million | +17.30% |
| 2022-12-31 | $97.09 Million | +2.40% |
| 2021-12-31 | $94.82 Million | +16.07% |
| 2020-12-31 | $81.69 Million | +86.94% |
| 2019-12-31 | $43.70 Million | +24.74% |
| 2018-12-31 | $35.03 Million | +47.54% |
| 2017-12-31 | $23.74 Million | +84.35% |
| 2016-12-31 | $12.88 Million | +10.54% |
| 2015-12-31 | $11.65 Million | +38.19% |
| 2014-12-31 | $8.43 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Viemed Healthcare Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 972.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $89.69 Million | 68.26% |
| Common Stock | $23.36 Million | 17.78% |
| Other Components | $18.34 Million | 13.96% |
| Total Equity | $131.39 Million | 100.00% |
Viemed Healthcare Inc Competitors by Market Cap
The table below lists competitors of Viemed Healthcare Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Power Mech Projects Limited
NSE:POWERMECH
|
$289.63 Million |
|
Miquel y Costas & Miquel S.A.
MC:MCM
|
$289.79 Million |
|
Chongqing Sanxia Paints Co Ltd
SHE:000565
|
$289.82 Million |
|
Shandong Minhe Animal Husbandry Co Ltd
SHE:002234
|
$289.84 Million |
|
Frasers Property Limited
PINK:FSRPF
|
$289.47 Million |
|
CGN New Energy Holdings Co. Ltd
PINK:CGEGF
|
$289.43 Million |
|
Zhongyin Babi Food Co. Ltd.
SHG:605338
|
$289.42 Million |
|
Hubei Chaozhuo Aviation Technology Co. Ltd. A
SHG:688237
|
$289.22 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Viemed Healthcare Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 113,895,000 to 131,393,000, a change of 17,498,000 (15.4%).
- Net income of 11,265,000 contributed positively to equity growth.
- Share repurchases of 1,069,000 reduced equity.
- Other factors increased equity by 7,302,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $11.27 Million | +8.57% |
| Share Repurchases | $1.07 Million | -0.81% |
| Other Changes | $7.30 Million | +5.56% |
| Total Change | $- | 15.36% |
Book Value vs Market Value Analysis
This analysis compares Viemed Healthcare Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.01x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 6.90x to 3.01x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $1.41 | $9.69 | x |
| 2015-12-31 | $1.94 | $9.69 | x |
| 2016-12-31 | $0.34 | $9.69 | x |
| 2017-12-31 | $0.63 | $9.69 | x |
| 2018-12-31 | $0.88 | $9.69 | x |
| 2019-12-31 | $1.10 | $9.69 | x |
| 2020-12-31 | $2.02 | $9.69 | x |
| 2021-12-31 | $2.33 | $9.69 | x |
| 2022-12-31 | $2.44 | $9.69 | x |
| 2023-12-31 | $2.82 | $9.69 | x |
| 2024-12-31 | $3.22 | $9.69 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Viemed Healthcare Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.57%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.02%
- • Asset Turnover: 1.27x
- • Equity Multiplier: 1.35x
- Recent ROE (8.57%) is below the historical average (32.13%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 112.11% | 40.59% | 2.29x | 1.20x | $8.61 Million |
| 2015 | 76.62% | 25.80% | 1.54x | 1.92x | $7.76 Million |
| 2016 | 9.53% | 3.92% | 1.27x | 1.92x | $-60.00K |
| 2017 | 34.43% | 17.42% | 1.25x | 1.59x | $5.80 Million |
| 2018 | 29.05% | 15.59% | 1.22x | 1.53x | $6.67 Million |
| 2019 | 19.51% | 10.62% | 0.97x | 1.89x | $4.16 Million |
| 2020 | 38.60% | 24.01% | 1.17x | 1.38x | $23.36 Million |
| 2021 | 9.62% | 7.80% | 0.99x | 1.24x | $-356.00K |
| 2022 | 6.41% | 4.48% | 1.19x | 1.21x | $-3.49 Million |
| 2023 | 8.99% | 5.60% | 1.18x | 1.36x | $-1.15 Million |
| 2024 | 8.57% | 5.02% | 1.27x | 1.35x | $-1.87 Million |
Industry Comparison
This section compares Viemed Healthcare Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Viemed Healthcare Inc (VMD) | $135.50 Million | 112.11% | 0.49x | $289.57 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |